[Utility of infliximab in gangrenous pyoderma not associated with inflammatory bowel disease].
Pérez-De Pedro
I
I
Gómez-Moyano
E
E
López-Carmona
D
D
Muñoz-Roca
N L
NL
De Ramón-Garrido
E
E
Camps-García
M T
MT
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D017511:Pyoderma Gangrenosum / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab